Ph.D.
Dr. Ilona Sviezhentseva is a cancer biologist whose research focuses on the molecular mechanisms of hematologic malignancies, personalized medicine, cancer stem cell biology, and translational cancer research. She is also interested in science communication, the sustainability of innovation ecosystems, and science policy, with a particular focus on the development of research and innovation systems in Ukraine.
Dr. Sviezhentseva is a Postdoctoral Research Associate at the Wilmot Cancer Institute, University of Rochester (Rochester, New York, USA). Her current research investigates how the bone marrow microenvironment contributes to acute myeloid leukemia progression and therapy resistance through interactions between leukemic cells and stromal cells.
From 2009 to 2012, Dr. Sviezhentseva worked as a Laboratory Assistant at the Center for Molecular and Cellular Research, National University of Kyiv-Mohyla Academy (Ukraine).
From 2012 to 2015, she was a Ph.D. student at the Department of Laboratory Diagnostics of Biological Systems at the National University of Kyiv-Mohyla Academy.
In 2016, she completed postdoctoral research at the Department of Immunology, Nicolaus Copernicus University (Poland).
From 2018 to 2020, she worked as a Medical Interpreter at the University of Western Ontario clinics (Canada).
From 2020 to 2021, she served as a Scientific Literature Reviewer for the Leukemia & Lymphoma Society of Canada.
From 2021 to 2022, she worked as a Science and Medical Journalist for Suspilne Media (Ukraine).
From 2022 to 2025, she was a Postdoctoral Research Fellow at Dana-Farber Cancer Institute and Harvard Medical School (Boston, Massachusetts, USA), where she studied the molecular mechanisms of acute lymphoblastic leukemia and therapeutic targeting of methionine metabolism.
Since 2026, she has been a Postdoctoral Research Associate at the University of Rochester(Rochester, NY, USA).
Frontires in Oncology, Vol.15, 04/08/2025. Amith Rangarajan, Ilona Sviezhentseva, Emma Gunderson, Yana Pikman, Matthew P. Jacobson, Beth Apsel Winger. Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, CA, United States, Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States
Role: Author